跳至主要内容
临床试验/KCT0006155
KCT0006155尚未招募未知

Pattern Identification and Herbal Prescrip-tion of Irritable Bowel Syndrome in a Korean Medicine Hospital

Kyung Hee University Oriental Medical Center0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
19?(Year) 至 65?(Year)(—)
性别
All

入选标准

  • Patient group
  • 1. Males and females aged 19 to under 65
  • 2. Participants with irritable bowel syndrome according to Rome IV diagnostic criteria
  • 3. Participants whose weekly average of the most severe abdominal pain over the past seven days was 3.0 or higher on a scale of 0 to 10
  • 4. Participants who have experienced stool type 6 or 7 according to the Bristol Stool Form Scale in the last seven days for at least two days.
  • 5. Participants who have confirmed that there are no clinically meaningful findings through colonoscopy performed within five years
  • 6. Participants who do not have clinically meaningful findings in physical examinations and clinical laboratory examinations
  • 7. Participants who voluntarily agreed to participate in the study
  • Healthy control group
  • 1. Males and females aged 19 to under 65
  • 2. Participants who do not have other functional/organic disorders, including gastrointestinal disorders, through an interview and physical examination
  • 3. Participants who have not experienced abdominal pain in the last seven days
  • 4. Participants who have not experienced stool type 6 or 7 according to the Bristol Stool Form Scale in the last seven days.
  • 5. Participants who do not have clinically meaningful findings in the physical examination and clinical laboratory examination
  • 6. Participants who voluntarily agreed to participate in the study

排除标准

  • Patient group
  • 1. Participants with a history of organic bowel diseases such as Crohn's disease, Celiac disease, Ulcerative colitis, and gastrointestinal malignancy
  • 2. Participants who have undergone major abdominal surgery such as gastrectomy or cholecystectomy (cf. Appendectomy and Hemorrhoidectomy are not major abdominal surgery)
  • 3. Participants with a history of major psychiatric diseases within two years
  • 4. Participants who have taken the following drugs within four weeks
  • - Systemic steroids
  • - Antipsychotics
  • - Antidepressants, anxiolytics, Z-drugs
  • 5. Participants who have taken the following drugs within two weeks
  • - Antibiotics
  • - Prokinetics
  • - Antispasmodics: anticholinergic/muscarinic drugs, smooth muscle relaxants, calcium channel blockers
  • - Antidiarrhoticas: loperamide, etc.
  • - Serotonin receptor agonists and antagonists: tegaserod, alosetron, etc.
  • - Non-steroidal anti-inflammatory drugs
  • - Bulk-forming laxatives (Dietary fiber preparations, etc), Osmotic laxatives
  • - Probiotics
  • Healthy control group
  • 1. Participants with a history of functional gastrointestinal disorders such as Irritable bowel syndrome, Functional constipation, Functional diarrhea, Functional abdominal discomfort
  • 2. Participants with a history of organic bowel diseases such as Crohn's disease, Celiac disease, Ulcerative colitis, and gastrointestinal malignancy
  • 3. Participants who have undergone major abdominal surgery such as gastrectomy or cholecystectomy (cf. Appendectomy and Hemorrhoidectomy are not major abdominal surgery)
  • 4. Participants with a history of major psychiatric diseases within two years
  • 5. Participants who have taken the following drugs within four weeks
  • -Systemic steroids
  • -Antipsychotics
  • -Antidepressants, anxiolytics, Z-drugs
  • 6. Participants who have taken the following drugs within two weeks
  • -Antibiotics
  • -Prokinetics
  • -Antispasmodics: anticholinergic/muscarinic drugs, smooth muscle relaxants, calcium channel blockers
  • -Antidiarrhoticas: loperamide, etc.
  • -Serotonin receptor agonists and antagonists: tegaserod, alosetron, etc.
  • -Non-steroidal anti-inflammatory drugs
  • -Bulk-forming laxatives (Dietary fiber preparations, etc), Osmotic laxatives
  • -Probiotics

研究者

发起方
Kyung Hee University Oriental Medical Center

相似试验